Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brian Bucher is active.

Publication


Featured researches published by Brian Bucher.


Transplantation | 2005

Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis.

Allan Tsung; Takashi Kaizu; Atsunori Nakao; Lifang Shao; Brian Bucher; Mitchell P. Fink; Noriko Murase; David A. Geller

Background. Hepatic ischemia-reperfusion injury (I/R) occurs in the settings of transplantation, trauma, and elective liver resections. Reactive oxygen species (ROS) have been shown to play a major role in organ I/R injury. Pyruvate, a key intermediate in cellular metabolism, is an effective scavenger of ROS. The purpose of this study was to test the hypothesis that ethyl pyruvate (EP), a soluble pyruvate derivative, is effective in preventing hepatic I/R injury. Methods. Lewis rats underwent 60 minutes of partial warm hepatic ischemia. Three doses of EP dissolved in lactated Ringer’s solution or lactated Ringer’s solution (LR) alone were given by intravenous injection. Serum and tissue samples were obtained at 1 to 24 hours postreperfusion. Results. Serum transaminases, degree of hepatic necrosis, and neutrophil infiltration were all significantly decreased in the EP-treated rats compared with control animals. The amount of hepatic lipid peroxidation was also significantly decreased in EP-treated animals. Both circulating levels and hepatic expression of inflammatory cytokines were significantly decreased in the EP-treated animals. Furthermore, EP inhibited activation of extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase mitogen-activated protein kinases, as well as nuclear factor-&kgr;B, signaling pathways involved in cytokine release. Treatment with EP also inhibited hepatic apoptosis. Conclusion. EP has a protective effect on hepatic I/R injury, mediated in part by decreasing lipid peroxidation, down-regulation of inflammatory mediators, and inhibition of apoptosis. Strategies using this additive to LR solution should be considered in clinical settings of ischemic liver injury to decrease organ damage.


Tetrahedron Letters | 2000

Selective sulfonylation of 1,2-diols and derivatives catalyzed by a recoverable fluorous tin oxide ☆

Brian Bucher; Dennis P. Curran

Abstract Fluorous tin oxide (C6F13CH2CH2)2SnO is readily synthesized, exhibits spectra that are generally similar to dibutyltin oxide and appears to exist as an oligomer or polymer. The fluorous tin oxide can be used catalytically to effect the selective monotosylation of 1,2-diols with TsCl/Et3N, and it can be readily recovered and reused.


Surgery | 2003

Protection of rat hepatocytes from apoptosis by inhibition of c-Jun N-terminal kinase

Eric L. Marderstein; Brian Bucher; Zhong Guo; Xuesheng Feng; Kaye Reid; David A. Geller


Hepatology | 2006

Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival

Takashi Kaizu; Atsushi Ikeda; Atsunori Nakao; Yoshihito Takahashi; Allan Tsung; Junichi Kohmoto; Hideyoshi Toyokawa; Lifang Shao; Brian Bucher; Koji Tomiyama; Michael A. Nalesnik; Noriko Murase; David A. Geller


Journal of Surgical Research | 2007

Glycochenodeoxycholate (GCDC) inhibits cytokine induced iNOS expression in rat hepatocytes

Brian Bucher; Xuesheng Feng; Geetha Jeyabalan; Baochun Zhang; Lifang Shao; Zhong Guo; David A. Geller


Organic Syntheses | 2002

(1'R)-(-)-2,4-O-ethylidene-d-erythrose and ethyl (E)-(-)-4,6-O-ethylidene-(4S, 5R, 1'R)-4,5,6-trihydroxy-2-hexenoate (1,3-dioxane-(R)-4-carboxaldehyde, 5-hydroxy-2-methyl-, [2R-(2α, 4α, 5β)]- and D-erythro-Hex-2-enonic acid,2,3-dideoxy-4,6-O-ethylidene-, ethyl ester [2E, 4(S)]-)

M. Fengler-Veith; O. Schwardt; U. Kautz; B. Krämer; V. Jäger; Brian P. Haney; Brian Bucher; Dennis P. Curran


The FASEB Journal | 2008

Development of siRNA systems to knock-down arginase I-specific or iNOS-specific gene expression

Zhong Guo; Brian Bucher; Lifang Shao; David A. Geller


Journal of Surgical Research | 2006

Nitric oxide (NO) decreases liver damage and caspase-3 activity during cholestatic liver injury

Brian Bucher; Geetha Jeyabalan; Takashi Kaizu; Xuesheng Feng; Noriko Murase; David A. Geller


Journal of Surgical Research | 2006

Donor graft adenoviral iNOS gene transfer improve transplant survival and ischemia / reperfusion injury

Atsushi Ikeda; Takashi Kaizu; Atsunori Nakao; Lifang Shao; Brian Bucher; Noriko Murase; David A. Geller


Transplantation | 2004

BENEFICIAL EFFECT OF CARBON MONOXIDE-INHALATION AGAINST ISCHEMIA/REPERFUSION INJURY AFTER RAT LIVER TRANSPLANTATION: POSSIBLE MECHANISM OF iNOS/NO PATHWAY BLOCKADE

Takashi Kaizu; L Sonis; E L. Marderstein; S L. Gleixner; Lifang Shao; Brian Bucher; Atsunori Nakao; Leo E. Otterbein; Augustine M. K. Choi; David A. Geller; Noriko Murase

Collaboration


Dive into the Brian Bucher's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lifang Shao

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Noriko Murase

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Takashi Kaizu

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zhong Guo

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Xuesheng Feng

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Allan Tsung

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Atsushi Ikeda

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge